4
Changes in Ownership
REVIVA PHARMACEUTICALS HOLDINGS, INC. Filed Acc 0001437749-26-009258
Options or other derivatives
- President and CEO acquired 150,075 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bhat Laxminarayan · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-18 | Grant or award : show line 1 in the form Stock Option (right to buy) | +109,150 | 109,150 | D |
| 2026-03-18 | Grant or award : show line 2 in the form Stock Option (right to buy) | +40,925 | 40,925 | I |
Loading xslF345X06/rdgdoc.xml…